TrialArthritis research & therapy2015

Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.

Jason M Gow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.